IP Library › Granted Patent US 9,045,725
Granted Patent B2
US 9,045,725 · App. 11/576,097 · Granted Jun 2, 2015

Devices and methods for integrated continuous manufacturing of biological molecules

Inventors: Jens Holger Vogel (Richmond, CA); Roberto Giovannini (Neuchatel, CH); Konstantin B. Konstantinov (Waban, MA); Huong My Nguyen (San Francisco, CA); Paul Wu (Orinda, CA)
Assignee: Bayer Healthcare LLC
C12M47/12C07K1/14B01D61/145B01D2311/14B01D2311/16B01D2313/10B01D2313/18B01D2317/04C07K1/145C07K1/34C07K14/755
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,045,725
App. No.
11/576,097
Granted
Jun 2, 2015
Kind
B2
Abstract

The present invention relates to a process and apparatus for purifying a molecule of interest from a heterogeneous clarified fluid mixture. The apparatus of the invention generally comprises a continuous perfusion fermentation system, a continuous particle removal system integrated with the perfusion fermentation system; and a continuous purification system integrated with the particle removal system, which is maintained under sterile conditions. The process comprises filtering a heterogeneous clarified fluid mixture by continuous ultrafiltration at a specific flow rate below the transition point of the molecule of interest in the pressure-dependent region of the flux versus TMP curve, wherein the specific flow rate is maintained substantially constant throughout the continuous ultrafiltration.

Claims (18)

1. A process for partially purifying and concentrating a labile protein of interest from a heterogeneous tissue culture fluid mixture, consisting of the steps:

(a) producing by a continuous perfusion fermentation process a heterogeneous tissue culture fluid mixture containing a labile protein of interest;

(b) transferring the tissue culture fluid mixture to a continuous particle removal process integrated with the continuous perfusion fermentation system;

(c) removing particulate contaminants from the tissue culture fluid in the continuous particle removal process to produce a clarified tissue culture fluid containing the protein of interest;

(d) transferring the clarified tissue culture fluid to one or more surge vessels integrated with the continuous particle removal process;

(e) optionally adjusting the pH, ionic strength, or protein stabilization properties of the clarified tissue culture fluid; and

(f) transferring the clarified tissue culture fluid to one or more convective ion exchange adsorber/desorber membranes integrated with the surge vessels; and

(g) purifying the protein of interest from the clarified tissue culture fluid in the convective ion exchange adsorber/desorber membranes to produce a particle-free, concentrated and partially purified protein of interest; wherein a specific flow rate of the mixture through the continuous perfusion fermentation process and continuous particle removal process is maintained substantially constant and wherein a loading flow rate through the convective ion exchange adsorber/desorber membrane is greater than the specific flow rate.

2. The process according to claim 1 , wherein the protein of interest is Factor VIII.

3. A process for partially purifying and concentrating a labile protein of interest from a heterogeneous tissue culture fluid mixture, consisting of the steps:

(a) producing by a continuous perfusion fermentation process a heterogeneous tissue culture fluid mixture containing a labile protein of interest;

(b) transferring the tissue culture fluid mixture to a continuous particle removal process integrated with the continuous perfusion fermentation system;

(c) removing particulate contaminants from the tissue culture fluid in the continuous particle removal process to produce a clarified tissue culture fluid containing the protein of interest;

(d) transferring the clarified tissue culture fluid to one or more surge vessels integrated with the continuous particle removal process;

(e) adjusting the pH, ionic strength, or protein stabilization properties of the clarified tissue culture fluid; and

(f) transferring the clarified tissue culture fluid to one or more convective ion exchange adsorber/desorber membranes integrated with the surge vessels; and

(g) purifying the protein of interest from the clarified tissue culture fluid in the convective ion exchange adsorber/desorber membranes to produce a particle-free, concentrated and partially purified protein of interest; wherein a specific flow rate of the mixture through the continuous perfusion fermentation process and continuous particle removal process is maintained substantially constant and wherein a loading flow rate through the convective ion exchange adsorber/desorber membrane is greater than the specific flow rate.

4. The process according to claim 3 , wherein the labile protein of interest is Factor VIII.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2008
From: VOGEL, JENS HOLGER; GIOVANNINI, ROBERTO; KONSTANTINOV, KONSTANTIN B; NGUYEN, HUONG MY; WU, PAUL
To: BAYER HEALTHCARE LLC
Reel/Frame 020764/0635 →
Continuity (2)
Provisional Application 60614995 · Sep 30, 2004
Related Publication 20080269468A1 · Oct 30, 2008